Methylation measurement: Bisulphite sequencing of blood and sperm genomic DNA c to analyse CpG dinucleotides in exon 21 of the KIF21A gene, commonly mutated in CFEOM1.
Methodological rigour: weak
Mutational analysis of a PCR d product from an affected individual identified the mutation c.2860C>T and, although less commonly, c.2861G>A in exon 21 of the KIF21A gene. These mutations combined accounted for 84% of the CFEOM1 cases. As both these mutations occurred in a CpG dinucleotide, methylation status was analysed by bisulphite sequencing.
Bisulphite sequencing found that the c.2860 and 2861 sites were methylated and that this methylation in part may account for the high mutability of these positions. Methylation measurement: Methylation array data collected in a previous study, [44] was subjected to subanalysis focusing on 2,227 miRNA probes of 463 miRNA genes. MethyLight analysis was also performed on an additional cohort of FECD cases and controls.
Methodological rigour: weak controls, predominantly DNA hypermethylation (71%, 154 probes, of FECD samples were hypermethylated compared to just 29%, or 62 hypomethylated probes). Differential methylation was predominantly seen within promoter regions (96%) and no significant methylation changes were seen with reference to age or sex.
Of the 154 hypermethylated probes, 74% were within intragenic sequences. Similarly, 71% of the 62 hypomethylated probes occurred in intragenic sequences, 44% of these being within intronic regions. MethyLight validation confirmed the differential methylation between cases and controls from the HumanMethylation450 array, with higher mean DNA methylation in FECD patients, as well as specific methylation of the miRNAs: miR-199A1 and miR-23B in FECD cases compared to controls.
An inverse relationship between hypermethylation and gene expression levels was see in 18 miRNAs, in particular the almost complete silencing of miR-199b-5p expression (which contained the highest level of promoter hypermethylation), suggesting a role in FECD pathogenesis.
A dual-luciferase reporter assay found that miR-199b-5p directly regulated Snail and ZEB1 mRNA transcripts, reducing expression levels significantly in human corneal endothelial cells. Farinelli, P. 2014
Reference number: 53 DNA methylation and differential gene regulation in To elucidate patterns of differential DNA methylation
In vivo interventional study using murine models. Population:
In all RP mice models, there was a general increase of methylation in the outer nuclear layer compared to any retinal layer of healthy Mice and rat models of RP, known as rd1 strains, used irrespective of gender and corresponding wild type strains. Ages were used corresponding to stages of retinal degeneration.
Methylation measurement: Immunofluorescence using anti-5 methylcytosine antibody, MeDIP h , DNA methylation microarray and gene mapping using 'cistrome platform peak2gene' software.
Methodological rigour: weak wild types, but not in the inner retinal layers of RP models. 5methylcystosine antibody co-labelled with dying cells in terminal deoxynucleotidyl transferase dUTP nick end labelling assay, indicating a link between DNA methylation and photoreceptor degeneration, particularly evident at the late stages of photoreceptor cell death.
DNA methylation measurement at whole tissue level found little difference between rd1 and wt, indicating that in contrast to cellular approach, whole tissue measurement of methylation may be insufficiently sensitive to detect a small number of cells showing strong DNA methylation. Microarray analysis showed 1284 hypermethylation genes in rd1 compared to wt in intragenic regions.
Hypermethylation of rd1 mice appeared to be greater in binding motifs of transcription factors YY1, E2F3 and NRL, all of which have possible roles in RP, and their target genes compared to wt.
DNMT i inhibition using decitabine increased survival of photoreceptors in short term cultures (4 days) from rd1 animal retinae compared to control (not treated) but not in long term cultures (11 days Methylation measurement: Conducted using the digoxigenin-labeled M27 beta probe to examine the XLRP2 gene methylation.
The opposite methylation pattern was observed in a phenotypically normal carrier.
There is a potential association between extreme skewed X chromosome inactivation and clinical severity.
No correlation between differential methylation status of X chromosomes and clinical severity.
García-Hoyos, M. 2005
Reference number: 48
New approach for the refinement of the location of the X-chromosome breakpoint in a previously described female patient with choroideremia carrying a X;4 translocation. DOI: 10.1002/ajmg.a.30 987
Elucidation of the role of the X chromosome breakpoints in choroideremia pathogensis.
Observational design: case report.
Population:
Female individual with choroideremia previously found to possess a balanced translocation between chromosomes X and 4.
Methylation measurement:
Methylation specific PCR analysis of bisulphite treated DNA.
Methodological rigour: weak
Expression analysis revealed the chromosomal breakpoint between primers CHM-4 and CHM-C. Skewed inactivation (almost complete inactivation) of the X chromosome was seen by the methylation specific PCR assay to be in a non-random pattern.
Jin, Z.B. 2008
Reference number: 51 Allelic copy number variation in FSCN2 detected using allelespecific genotyping and multiplex realtime PCRs. DOI: 10.1167/iovs.07-1656
Investigation of the FSCN2 c.72delG mutation in patients with RP.
Observational design: case-control.
Population: Three RP and three normal control participants, as well as a fourth additional RP participant with an asymmetric allele ratio of 4:1 including an extra copy of the wild-type allele. Methylation measurement: Bisulphite conversion of DNA was processed using a methylation specific PCR assay, followed by cloning of PCR products in a vector (pCR4-TOPO) which Bisulphite converted DNA from 20 clones showed no significantly different methylation pattern between healthy controls and RP participants, as well as no significant difference in methylation levels between alleles containing the FSCN2 c.72delG mutation and alleles without, indicating no preferential monoallelic imprinting. 
Methodological rigour: weak
Of the probes for COL8A1, TCF4, SLC4A11, and AGBL genes, previously identified to be associated with late onset FECD, the vast majority did not yield a statistically significant difference in methylation with the exception of SLC4A11 (14/16 probes). However, 10,961 other probes showed a significant difference in methylation with a false discovery rate of 0.01. Of these, 59% displayed hypermethylation and 41% displayed hypomethylation. No probes were significantly differentially methylated when comparing age or sex.
Gene ontology analysis showed gene body hypomethylation occurred disproportionately in 
Levels of H3K4me3 were high in wild type cells compared to GCD2 cells in TGFβ1 promoter region, whilst H3K27me3 p levels were low in both cells. DNA methylation levels were not significantly different between the two cell types.
TGFβ1 increased active H3K4me1 q and H3K4me3 levels in TGFβ1 and other extra cellular matrix associated gene promoters in wt fibroblasts but not in GCD2-homozygous cells, correlated with increased expression of TGFβ1 induced genes. The repressive H3K27me3 decreased in wildtype fibroblasts following TGFβ1 treatment, but again no effect was found in GCD2-homozygous cells.
Increases in H3K4me1/3 and decreases in
H3K27me3 at TGFBIp and extra cellular matrix gene promoters plays a role in GCD2 pathogenesis. 
Abbreviations.
a CFEOM1: congenital fibrosis of extraocular muscles-1, b CpG: 5'-C-phosphate, c DNA: Deoxyribonucleic acid, d PCR: polymerase chain reaction, e miRNA: microRNA, f FECD: Fuch's endothelial corneal dystrophy, g RP: retinitis pigmentosa, h MeDIP: methylated DNA immunoprecipitation, i DNMT: DNA methyl transferase, j XLRP2: X-linked Retinitis Pigmentosa 2, k HM450: Illumina Infinium HumanMethylation450, l H3Kme3: histone 3 Lysine trimethylation, m GCD2: granular corneal dystrophy type 2, n ChIP: chromatin immunoprecipitation, o MeDIA: methylated DNA isolation assay, p H3K27me3: histone 3 lyisne 27 trimethylation, q H3K4me1: histone 3 lysine 4 methylated, r MRSE-PCR: methylation sensitive restriction enzyme-polymerase chain reaction, s TMT: tandem mass tag labelling, t HPLC: high performance liquid chromatography, u H3K9me3: Histone 3 Lysine 9 trimethylation, v H3K79me3: histone 3 lysine 79 trimethylation, w RNA: ribonucleic acid. 
